Clinical, manufacturing, safety, and commercial teams all lean on shared data. They need to agree on who publishes each data product, who can use it, and what evidence goes with it.
|Articles|January 2, 2014
- Pharmaceutical Technology-01-02-2014
- Volume 38
- Issue 1
ALpHA G Capsule Filter for Single-Use Systems
Author(s)Melanie Sena
ALpHA G Capsule Filter for Single-Use Systems
The ALpHA G is an absolute rated depth type prefilter, which has been optimized for compatibility with a gamma irradiation cycle commonly used to sterilize single-use systems. ALpHA G features a tapered pore structure, which provides high flow rates and delivers increased dirt holding capacity. ALpHA G capsule filters are available in retention ratings from 0.6 μm to 20 μm. The filter can be specified in a wide range of capsule configurations to provide seamless scalability from laboratory work and process development through production. For applications requiring multistage filtration and larger surface areas than can be accommodated by a single filter, the ALpHA G media can be specified in the UltraSnap filter assembly. The UltraSnap assembly can be delivered as a single presterilized unit with one inlet and one outlet for maximum convenience and plug and play functionality.
Articles in this issue
over 12 years ago
UK Biotech Gains Momentumalmost 13 years ago
Drugs, At What Cost?almost 13 years ago
CS Inspection Machine Improves Efficiencyalmost 13 years ago
Ribbon Blender Model 42N-270 Increases Performancealmost 13 years ago
Innovation and Market Growth in Brazilalmost 13 years ago
R&D in Transitionalmost 13 years ago
Battling Off-Weight Tabletsalmost 13 years ago
Metrics Sought to Ensure Drug Qualityalmost 13 years ago
Gericke N200 Nibbler Provides Size Reductionalmost 13 years ago
Qualifying Personnel to Visually Inspect Cleaned EquipmentRelated to this article
Continuous overall equipment effectiveness can be used to pinpoint hidden downtime and process bottlenecks in real time.
The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Bill Williams, AAPS, compares KinetiSol and spray drying for amorphous solid dispersions, covering 75% drug loading, pill burden, weakly basic drug release, and process limits.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Trending on Pharmaceutical Technology
1
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
2
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
3
AAPS PharmSci 360 2026: Spray Drying and ASD
4
RRP Accelerated Approval: What VOCERYQ Means for Manufacturing Teams
5